Expression and regulation of neuropilin-1 in human astrocytomas

International Journal of Cancer

Volumn 88, Issue 4, 2000, Pages 584-592

  Ding, Hao ^a   Wu, Xiaoli ^a   Roncari, Luba ^a   Lau, Nelson ^a   Shannon, Patrick ^b   Nagy, Andras ^a,c   Guha, Abhijit ^a,b,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGENIC AGENT; NEUROPILIN; PROTEIN P21; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; WESTERN BLOTTING;

ANIMALS; ASTROCYTOMA; BREAST NEOPLASMS; CELL HYPOXIA; COLONIC NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROPILIN-1; PROTO-ONCOGENE PROTEINS P21(RAS); RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033766256     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001115)88:4<584::AID-IJC11>3.0.CO;2-T     Document Type: Article

References (56)

1. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
2. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
3. Ras oncogenes in human cancer: A review
4. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
5. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
6. Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability
7. Genetic alterations in gliomas
8. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
9. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
10. Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elements
11. Normoxic and hypoxic regulation of vascular endotheliaL growth factor (VEGF) by astrocytoma cells is mediated by Ras
12. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
13. Tumor angiogenesis and tissue factor
14. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
15. Receptors for collapsin/semaphorins
16. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity
17. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
18. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin- 1 in human vascular endothelial cells
19. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
20. Proliferation of human malignant astrocytomas is dependent on Ras activation
21. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors
22. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors
23. Neuropilin is a receptor for the axonal chemorepellent semaphorin III
24. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
25. Hypoxia-induced transcriptional activation and increased mRNA stability of VEGF in C6 glioma cells
26. A requirement for neuropilin-1 in embryonic vessel formation
27. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice
28. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs
29. The new WHO classification of brain tumours
30. Neuropilin is a semaphorin III receptor
31. Transcriptional regulation of the rat VEGF gene by hypoxia
32. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
33. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer
34. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors
35. Neuropilin-1 is a placenta growth factor-2 receptor
36. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo
37. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele
38. Vascular endothelial growth factor (VEGF) and its receptors
39. Evidence for progressional changes in the human malignant glioma line U- 343 MGa: Analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived growth factor
40. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
41. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
42. Angiogenesis in malignant gliomas
43. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
44. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
45. Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: Comparison of parental and Ras-overproducing NIH 3T3 fibroblasts
46. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
47. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
48. Vacular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
49. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain
50. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
51. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients
52. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
53. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
54. Vascular endothelial growth factor expression in transplanted human hearts
55. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
56. Signaling pathways in Ras-mediated tumorigenicity and metastasis